New oral antithrombotics: a need for laboratory monitoring. For
New oral antithrombotics: a need for laboratory monitoring. Against
ADAMTS-13 assays in thrombotic thrombocytopenic purpura
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding
Assessment of renal dysfunction improves troponin-based short-term prognosis in patients with acute symptomatic pulmonary embolism
Fine particulate: it matters
Effects of inhalable particulate matter on blood coagulation
Air pollution and hospitalization for venous thromboembolic disease in Chile
How can we reduce disagreement among guidelines for venous thromboembolism prevention?
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review
Differences in clinical presentation of pulmonary embolism in women and men
Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies
Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)
Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion
Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring
Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users
Thrombin generation-based assays to measure the activity of the TFPI–protein S pathway in plasma from normal and protein S-deficient individuals
Thrombin generation in morbid obesity: significant reduction after weight loss
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes
Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia
Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor
Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets
Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor
A new role for the A2b adenosine receptor in regulating platelet function
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood
Influence of natural SERPINC1 mutations on ex vivo thrombin generation
High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis
Prospective observational cohort study of bioaccumulation of dalteparin at a prophylactic dose in patients with peritoneal dialysis
Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short-term clinical outcome in normotensive patients suspected of having acute pulmonary embolism
HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians
Genetic testing in von Willebrand disease: a rebuttal
Genetic testing in von Willebrand disease: reply to rebuttal
Join ISTH